LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 92.71 | 17.25 | 10127 | 6184 | 1.6376 | 1.1197 | MN20160310_N02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 94.68 | 17.25 | 6 | 6239 | 0.0010 | -0.1169 | MN20160310_N02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 94.68 | 17.25 | 13321 | 6239 | 2.1350 | 1.1867 | MN20160310_N02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 94.68 | 17.25 | 10164 | 6239 | 1.6290 | 1.1182 | MN20160310_N02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.06 | 17.25 | 247 | 143 | 1.7247 | 1.3909 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.06 | 17.25 | 466 | 143 | 3.2539 | 1.9434 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.03 | 17.25 | 412 | 273 | 1.5072 | 1.2168 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.03 | 17.25 | 744 | 273 | 2.7217 | 1.5711 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.01 | 17.25 | 597 | 389 | 1.5327 | 1.1992 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.01 | 17.25 | 945 | 389 | 2.4262 | 1.4357 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.98 | 17.25 | 769 | 445 | 1.7278 | 1.2474 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.98 | 17.25 | 1016 | 445 | 2.2828 | 1.3849 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.95 | 17.25 | 2 | 471 | 0.0042 | -0.3633 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.95 | 17.25 | 841 | 471 | 1.7834 | 1.2577 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | I20 |